Maha Katabi
Directeur/Bestuurslid bij AEROVATE THERAPEUTICS, INC.
Vermogen: - $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Maha Katabi
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
McGill University
526
| College/University | Other Consumer Services | 526 |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California.
31
| Private Company | Investment Managers | 31 |
Sectoral Asset Management, Inc.
Sectoral Asset Management, Inc. Investment ManagersFinance Sectoral Asset Management, Inc. (Sectoral) is an investment management firm headquartered in Montréal, Canada. The firm was founded in 2000 by Jérôme G. Pfund and Michael J. Sjöström. They are a wholly-owned subsidiary of Sectoral Asset Management Holding Ltd. in Hong Kong. Sectoral manages public and private equity healthcare strategies for investors around the world. Their clients include sovereign wealth funds, private banks, and family offices. In addition, they have long-standing sub-advisory relationships with institutional investors in Europe and Asia.
22
| Subsidiary | Investment Managers | 22 |
Public Company | Biotechnology | 21 | |
Public Company | Biotechnology | 19 | |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada.
18
| Private Company | Biotechnology | 18 |
Public Company | Biotechnology | 17 | |
Ventures West Management, Inc.
Ventures West Management, Inc. Investment ManagersFinance Ventures West Management, Inc. is venture capital firm headquartered in Vancouver, British Columbia with additional offices in Toronto, Montréal and Kanata, Ontario
10
| Extinct | Investment Managers | 10 |
Private Company | Biotechnology | 10 | |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom.
7
| Subsidiary | Biotechnology | 7 |
Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021.
6
| Holding Company | Biotechnology | 6 |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands.
3
| Holding Company | Biotechnology | 3 |
Ascendis Pharma, Inc.
1
| Subsidiary | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Maha Katabi via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Stanford University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director/Board Member President | |
GILEAD SCIENCES, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Private Equity Investor Private Equity Investor | |
KARA THER | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member President | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
University of Pennsylvania | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
University of Illinois | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Compliance Officer | |
TURG POIN | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Executive Officer | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Founder Chairman Founder | |
University of California | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
MERCK & CO., INC. | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
SURFACE ONCOLOGY, INC. | Biotechnology | Chief Executive Officer Chief Operating Officer Director/Board Member | |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Chairman Director/Board Member | |
Franklin Biotechnology Discovery Fund | Investment Trusts/Mutual Funds | Founder Corporate Officer/Principal | |
CRISPR THERAPEUTICS AG | Biotechnology | Director/Board Member Director/Board Member | |
University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree | |
ACCELERON PHARMA INC. | Biotechnology | Corporate Officer/Principal Chief Executive Officer | |
venBio Partners LLC
venBio Partners LLC Investment ManagersFinance venBio Partners LLC (venBio) is a private equity subsidiary of Venbio Partners LP founded in 2009 by Adelman robert and Goodman corey. The firm is headquartered in San Francisco, California. | Investment Managers | Founder Private Equity Investor | |
PEPGEN INC. | Biotechnology | Director/Board Member Director/Board Member | |
AVROBIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Delinea, Inc. (United States)
Delinea, Inc. (United States) BiotechnologyHealth Technology Delinia, Inc. operates as a biotechnology company that develops novel therapeutics for the treatment of autoimmune diseases. Its main program is a molecule that potentiates and expands Regulatory T Cells, powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the path physiology of cancer and autoimmune disease. Delinia was founded by Michael Rosenblum and Jeffrey Greve in 2015 and is headquartered in Summit, NJ. | Biotechnology | Director/Board Member Director/Board Member | |
The Johns Hopkins University | College/University | Undergraduate Degree Undergraduate Degree | |
Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree Doctorate Degree | |
Franklin Advisers, Inc.
Franklin Advisers, Inc. Investment ManagersFinance Franklin Advisers, Inc. is a mutual fund manager and registered investment advisor headquartered in San Mateo, California. The firm was founded in 1985 and is a subsidiary of Franklin Resources, Inc. (NYSE: BEN), a holding company that, together with its various subsidiaries is referred to as Franklin Templeton Investments. Franklin Advisers provides investment advisory and portfolio management services to US and non-US, registered open-end and closed-end funds and unregistered funds, as well as separate accounts. | Investment Managers | Portfolio Manager-Equities Analyst-Equity | |
The Schulich School of Business | College/University | Masters Business Admin Masters Business Admin | |
VAXCYTE, INC. | Biotechnology | Director/Board Member Chairman | |
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Orbus Therapeutics, Inc.
Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
BioVectra, Inc.
BioVectra, Inc. Pharmaceuticals: MajorHealth Technology BioVectra, Inc. manufactures and supplies custom active pharmaceutical ingredients to the North American and European markets. It offers specialty and fine chemicals, advanced intermediates, enzymes and biomolecules, as well as provide custom synthesis and manufacturing services for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company was founded by Regis J. Duffy in 1970 and is headquartered in Charlottetown, Canada. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
AUSPEX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member President | |
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
The University of Texas Southwestern Medical Center | College/University | Corporate Officer/Principal Graduate Degree | |
Pionyr Immunotherapeutics, Inc.
Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
University of Toronto | College/University | Masters Business Admin Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 44 |
Canada | 5 |
Zwitserland | 2 |
Verenigd Koninkrijk | 2 |
Ierland | 2 |
Sectoraal
Health Technology | 30 |
Consumer Services | 17 |
Finance | 4 |
Commercial Services | 2 |
Miscellaneous | 2 |
Operationeel
Director/Board Member | 419 |
Corporate Officer/Principal | 148 |
Independent Dir/Board Member | 96 |
Undergraduate Degree | 87 |
Chief Executive Officer | 69 |
Sterkste connecties
Insiders | |
---|---|
Patrick Enright | 41 |
Beth Seidenberg | 39 |
Joshua Resnick | 36 |
Kurt von Emster | 34 |
Michael Grey | 32 |
Samuel Saks | 28 |
Mark Iwicki | 26 |
Dave Grayzel | 23 |
Michael Gladstone | 23 |
Donald Santel | 20 |
Chris Hollowood | 19 |
Aaron Kantoff | 19 |
Gordon McCauley | 18 |
Jerel Banks | 18 |
Richard Gaster | 17 |
- Beurs
- Insiders
- Maha Katabi
- Bedrijfsconnecties